相关实验视频

Updated: Feb 19, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

通过在血栓中存在的激动剂调节血小板收缩性

Dishon W Hiebner¹, Smita Patil¹, Martin Kenny²

¹Royal College of Surgeons in Ireland, Dublin, Ireland.

|February 17, 2026

概括

血栓素通过激活特定的信号通路,显著提高血小板收缩性和血栓稳定性. 这一发现对于了解血液静止和联合抗血小板和抗凝固疗法的潜在风险至关重要.

科学领域:

生物医学工程生物医学工程
细胞生物学细胞生物学
血液学血液学血液学

背景情况:

细胞引力对于组织发育至关重要.
血小板形成分层的瘤,具有明显的核心和外结构.
血栓核心的稳定性可能取决于血小板收缩性和微环境相互作用.

研究的目的:

为了研究血小板激动剂如何调节血栓内actomyosin收缩性.
为了澄清血栓形成中血小板收缩率的空间调节.

主要方法:

在体外测量单个血小板的收缩力.
蛋白酶激活受体 (PAR) 信号通路的分析.
评估Rho相关蛋白激酶 (ROCK) 和肌光链 (MYL) 酸化.
评估抗血小板药物在抵消凝块收缩方面的有效性.

主要成果:

与ADP或与原相关的相比,素诱导的引力显著更高 (~50%).
联合刺激PAR1和PAR4可以最大限度地提高血小板的收缩性.
凝血素通过PAR>Gα13>RhoA信号传递独特地触发了持续的ROCK2和MYL9酸化.
氨酸增加了MYL9蛋白表达和ROCK1前mRNA剪接.
抗血小板药物以与血栓度相关的方式抑制了血块收缩.

结论:

血栓素在最大限度地提高持续的血小板收缩性,稳定静血栓的关键作用.
这项研究阐明了血栓和血小板之间的时空关系在血液静止.
结合抗血小板和抗凝固治疗可能会增加由于凝块收缩受损的出血风险.

更多相关视频

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

相关概念视频

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...